10.10.25 -- Derisking AI Means First Asking: Who Does It Serve?

Product recalls are becoming a major concern in life sciences. Learn why your company must act now to strengthen quality systems and reduce risk across pharmaceuticals, devices, and biologics.

Explore the fundamental science behind antibody-oligonucleotide conjugates (AOCs), including oligonucleotide synthesis, bioconjugation strategies, and the challenges that arise from their properties.

Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.

Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS.

A rigorous, proactive approach is essential for excellence in pharmaceutical manufacturing. Learn how embedding rigor in systems, workflows, and workforce capabilities improves compliance and efficiency.

Join top validation experts for a dynamic panel discussion on the 2025 State of Validation Report—uncovering key trends, challenges, and innovations shaping pharmaceutical validation practices today.

A cost-effective approach with a comprehensive AAV analytical package holds the potential to advance the application of rAAV in cell and gene therapy for the treatment of human diseases.

Explore the rising challenges of recall management in life sciences. This six-part series offers expert insights and unveils a groundbreaking solution set to transform how companies manage recalls.

Learn why generic EAM systems fall short in regulated industries and how purpose-built solutions ensure compliance, efficiency, and audit readiness.

Western blotting identifies specific proteins in complex samples, using gel electrophoresis and antibody probing. Find out how it reveals protein presence, abundance, and size.

Discover an essential aspect of development that ensures gene therapy products remain safe, stable, and effective throughout preparation and administration by simulating real-world clinical conditions.

Modern lab equipment is essential to scientific research, but maintaining it is increasingly complex. Discover key challenges and strategies to futureproof your maintenance approach.

Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.

Explore how ISO 14644 and EU GMP Annex 1 shape cleanroom standards, with a focus on particle control, system accuracy, and the surprising impact of tubing length limitations.

Investigations into viable air excursions are difficult to perform using traditional methods. Discover why a real-time viable particle counter is key to providing process improvement.

See how simplified, in-line analytics are changing the way CDMOs manage product concentration in fed-batch and perfusion processes.

Implement strategies to reduce unplanned downtime and keep your biomanufacturing on track with a checklist and planning to enhance reliability and resilience.

Learn about a method that utilizes monoclonal antibodies and flow cytometry to analyze the metabolic state of individual immune cells, advancing immune research and immunotherapy.

Discover a CHO AOF panel that provides rapid detection of relevant adventitious viral contaminants in bulk harvest material, and explore data showing equivalent sensitivity to the in vitro assay.